ARCHIVES

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

This article is from The Cancer Letter archive.

Vol. 09 No. 40 | October 21, 1983

Download PDF Visit The Full Archive

Related Articles

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999

ASCO Board Accepts Plan To Establish New Bethesda Headquarters, Hire Chief Officer

April 23, 1993

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988

NIH Offers Grant Funds for Support of Minority, Disabled Researchers

February 16, 1996

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012